Panel Discussion: Phase 0 for Radiopharmaceuticals: Benefits & Risks
Time: 12:00 pm
day: P&T Track AM
Details:
- Uncovering the rationale behind conducting these preliminary studies
- Exploring the pharmacokinetic and pharmacodynamic data it can provide
- Considerations for initiating a phase 0 trial
